Back to Search Start Over

Optoacoustic biomarkers of lipids, hemorrhage and inflammation in carotid atherosclerosis.

Authors :
Karlas A
Fasoula NA
Kallmayer M
Schäffer C
Angelis G
Katsouli N
Reidl M
Duelmer F
Al Adem K
Hadjileontiadis L
Eckstein HH
Ntziachristos V
Source :
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Nov 09; Vol. 10, pp. 1210032. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).
Publication Year :
2023

Abstract

Imaging plays a critical role in exploring the pathophysiology and enabling the diagnostics and therapy assessment in carotid artery disease. Ultrasonography, computed tomography, magnetic resonance imaging and nuclear medicine techniques have been used to extract of known characteristics of plaque vulnerability, such as inflammation, intraplaque hemorrhage and high lipid content. Despite the plethora of available techniques, there is still a need for new modalities to better characterize the plaque and provide novel biomarkers that might help to detect the vulnerable plaque early enough and before a stroke occurs. Optoacoustics, by providing a multiscale characterization of the morphology and pathophysiology of the plaque could offer such an option. By visualizing endogenous (e.g., hemoglobin, lipids) and exogenous (e.g., injected dyes) chromophores, optoacoustic technologies have shown great capability in imaging lipids, hemoglobin and inflammation in different applications and settings. Herein, we provide an overview of the main optoacoustic systems and scales of detail that enable imaging of carotid plaques in vitro , in small animals and humans. Finally, we discuss the limitations of this novel set of techniques while investigating their potential to enable a deeper understanding of carotid plaque pathophysiology and possibly improve the diagnostics in future patients with carotid artery disease.<br />Competing Interests: VN discloses financial interests to iThera Medical GmbH, Spear UG, i3 Inc and sThesis GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (© 2023 Karlas, Fasoula, Kallmayer, Schäffer, Angelis, Katsouli, Reidl, Duelmer, Al Adem, Hadjileontiadis, Eckstein and Ntziachristos.)

Details

Language :
English
ISSN :
2297-055X
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in cardiovascular medicine
Publication Type :
Academic Journal
Accession number :
38028502
Full Text :
https://doi.org/10.3389/fcvm.2023.1210032